BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study.
189 auth. K. Ray, B. Molemans, W. Schoonen, P. Giovas, S. Bray, Gaia Kiru, Jennifer Murphy, M. Banach, S. de Servi, D. Gaita, I. Gouni-Berthold, G. Hovingh, J. Jozwiak, J. Jukema, R. Kiss, ... S. Kownator, H. Iversen, V. Maher, L. Masana, A. Parkhomenko, A. Peeters, P. Clifford, K. Rašlová, P. Siostrzonek, S. Romeo, D. Tousoulis, C. Vlachopoulos, M. Vrablík, A. Catapano, N. Poulter, P. Siostrzonek, A. Peeters, M. Vrablík, H. Iversen, S. Kownator, I. Gouni-Berthold, C. Vlachopoulos, D. Tousoulis, R. Kiss, V. Maher, S. de Servi, J. Jukema, J. Jozwiak, D. Gaita, K. Rašlová, L. Masana, S. Romeo, P. Clifford, O. Parkhomenko, K. Distelmaier, T. Stulnig, H. Drexel, C. Ebenbichler, R. Zweiker, H. Brath, Gudrun Zweiker, L. Janssens, P. van de Borne, A. Leone, R. Lemmens, A. Verhaegen, M. De Meulemeester, Y. Balthazar, S. Heijmans, Y. Calozet, N. Paquot, S. Carlier, D. Hemelsoet, T. Velimský, P. Kolečkář, I. Kellnerová, V. Čech, J. Macháč, N. Král, B. Seifert, J. Škrobáková, J. Krupička, J. Lindholt, C. Kruuse, E. Touzé, J. Constans, J. Renucci, P. Steg, N. Chakfé, M. Farnier, Franck Bocarra, G. Faulmann, F. Schaper, B. Manfras, A. Schäfer, N. Weiss, F. Dellanna, U. Schatz, M. Elisaf, G. Dalekos, D. Bereczki, Katalin Farkas, Martyin Tibor, L. Feher, V. Kiss, R. Kiss, L. Márk, P. Harrington, B. Mcadam, B. O'Doherty, P. O’Connor, D. Molony, M. Averna, R. Cemin, F. Verzini, G. Derosa, Salvatore Novo, F. Giorgino, F. de Leeuw, G. Hovingh, P. van der Harst, F. Visseren, J. Jozwiak, G. Gajos, M. Lukaszewicz, J. Kasprzak, Maciej Banach, S. Kasperczyk, Jarosław Krawczyk, A. Cerghizan, Noemi Pletea, M. Popescu, Ionut Donoiu, I. Ionescu, B. Raska, Peter Bojčík, J. Masjuán-Vallejo, E. Jódar, F. Gomez-Delgado, F. Tinahones, Alfonso Soto González, Jaime García de Tena, C. Brotons, A. Gottsäter, A. Laska, Å. Olsson, C. Lindholm, N. Abrahamsson, P. Ainsworth, C. Bicknell, I. Chetter, P. Eavis, P. Guyler, T. Hall, R. Hinchliffe, P. Holt, W. M. Turner, David Weston, David Macfarlane, K. Muir, D. Scott, M. Bown, O. Karpenko, I. Vakaliuk, I. Rudyk, O. Korzh, Larysa M Yena, Kopytsya Mykola Pavlovych, Halyna Myshanych, O. Kulynych, O. Voloshyna, Gaia Kiru, Jennifer Murphy, Kamela Aliaj, Janis Best-Lane, K. Boland, C. Brennan, Sarah Chopping, M. Durkina, Felicia Frost, P. Jadav, Rosemary Keshinro, J. Smith, J. Sukumar, Charlene Turpin, Amanda Bravery, N. Das, Ayse Depsen, Kayode Disu, A. I. Ion, Nikki O’Sullivan, Vivienne Okona-Mensah, D. Sivakumar, G. Picot
8 2020
8
🐜
🐢 A global view on the development of non communicable diseases.
K. Wagner, H. Brath
8 2012
8
🐢
🐜 PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
11 auth. M. Huelsmann, S. Neuhold, M. Resl, Guido Strunk, H. Brath, C. Francesconi, ... C. Adlbrecht, R. Prager, A. Luger, R. Pacher, M. Clodi
8 2013
8
🐜
🐜 Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
9 auth. M. Remely, E. Aumueller, Christine Merold, S. Dworzak, B. Hippe, Julia Zanner, ... A. Pointner, H. Brath, A. Haslberger
7 2014
7
🐜
🐜 HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
12 auth. T. Danne, B. Cariou, Phillip L. Banks, M. Brandle, H. Brath, E. Franek, ... J. Kushner, P. Lapuerta, D. McGuire, A. Peters, Sangeeta Sawhney, P. Strumph
7 2018
7
🐜
🐜 Effects of combined inspiratory muscle and cycle ergometer training on exercise performance in patients with COPD.
7 auth. T. Wanke, D. Formanek, H. Lahrmann, H. Brath, M. Wild, C. Wagner, ... H. Zwick
7 1994
7
🐜
🐬 Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
M. Remely, E. Aumueller, D. Jahn, B. Hippe, H. Brath, A. Haslberger
6 2014
6
🐬
🐬 Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss.
M. Remely, B. Hippe, Julia Zanner, E. Aumueller, H. Brath, A. Haslberger
6 2016
6
🐬
🦁 Mobile health (mHealth) based medication adherence measurement – a pilot trial using electronic blisters in diabetes patients
8 auth. H. Brath, J. Morak, T. Kästenbauer, R. Modre-Osprian, Hermine Strohner-Kästenbauer, Mark Schwarz, ... W. Kort, G. Schreier
6 2013
6
🦁
🐜 Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite.
12 auth. M. Stadler, Larissa Tomann, A. Storka, M. Wolzt, S. Peric, C. Bieglmayer, ... G. Pacini, S. Dickson, H. Brath, P. Bech, R. Prager, M. Korbonits
6 2014
6
🐜
🐜 Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)
14 auth. Chantal Mathieu, A. Barnett, H. Brath, I. Conget, J. Castro, R. Göke, E. M. Rodriguez, P. Nilsson, E. Pagkalos, A. Penfornis, ... N. Schaper, S. Wangnoo, W. Kothny, G. Bader
5 2013
5
🐜